Literature DB >> 17063349

[Economic aspects of evidence-based metaphylaxis].

W L Strohmaier1.   

Abstract

The calculation model which we developed for the cost of stone therapy and metaphylaxis in Germany some years ago with a social health insurance company is based on estimates of stone incidence, types and recurrence rates, actual costs for stone removal, and metaphylaxis (based on data from a district of the social health care system). There are 200,000 stone recurrences per year in Germany. Costs for treatment of these stones amount to $687,000,000. Stone metaphylaxis reduces the recurrence rate by some 40%. The annual cost for stone removal could be lowered by $275,300,000. Metabolic evaluation/metaphylaxis amount to $70,100,000 per year, resulting in a net saving of $205,200,000. In 1997, there were 96 days off work per stone patient resulting in 5,800,000 days off work in Germany per year. Metaphylaxis is not only medically effective in stone formers but also can lower health care cost significantly. Although health care conditions may vary from country to country, in principle this calculation model is applicable also to other countries.

Entities:  

Mesh:

Year:  2006        PMID: 17063349     DOI: 10.1007/s00120-006-1220-6

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  10 in total

1.  [Socioeconomic aspects of urinary calculi and metaphylaxis of urinary calculi].

Authors:  W L Strohmaier
Journal:  Urologe A       Date:  2000-03       Impact factor: 0.639

2.  Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs. 2000.

Authors:  A Hesse; E Brändle; D Wilbert; K-U Köhrmann; P Alken
Journal:  Eur Urol       Date:  2003-12       Impact factor: 20.096

3.  New stone formation: a comparison of extracorporeal shock wave lithotripsy and percutaneous nephrolithotomy.

Authors:  L K Carr; J D'A Honey; M A Jewett; D Ibanez; M Ryan; C Bombardier
Journal:  J Urol       Date:  1996-05       Impact factor: 7.450

4.  International comparison of cost effectiveness of medical management strategies for nephrolithiasis.

Authors:  Yair Lotan; Jeffrey A Cadeddu; Margaret S Pearle
Journal:  Urol Res       Date:  2005-05-28

Review 5.  Summary of the National Institutes of Arthritis, Diabetes, Digestive and Kidney Diseases conference on urolithiasis: state of the art and future research needs.

Authors:  M I Resnick; L Persky
Journal:  J Urol       Date:  1995-01       Impact factor: 7.450

6.  Direct and indirect costs of nephrolithiasis in an employed population: opportunity for disease management?

Authors:  Christopher S Saigal; Geoffrey Joyce; Anga R Timilsina
Journal:  Kidney Int       Date:  2005-10       Impact factor: 10.612

7.  Nephrolithiasis and risk of hypertension.

Authors:  F Madore; M J Stampfer; E B Rimm; G C Curhan
Journal:  Am J Hypertens       Date:  1998-01       Impact factor: 2.689

8.  Renal stone disease in a Swedish district during one year.

Authors:  C Ahlstrand; H G Tiselius
Journal:  Scand J Urol Nephrol       Date:  1981

9.  The fate of residual fragments after extracorporeal shock wave lithotripsy monotherapy of infection stones.

Authors:  E M Beck; R A Riehle
Journal:  J Urol       Date:  1991-01       Impact factor: 7.450

10.  When is medical prophylaxis cost-effective for recurrent calcium stones?

Authors:  Paramjit S Chandhoke
Journal:  J Urol       Date:  2002-09       Impact factor: 7.450

  10 in total
  6 in total

Review 1.  [Recurrence prevention of urolithiasis with respect to economic aspects].

Authors:  R Siener; N Laube; W L Strohmaier
Journal:  Urologe A       Date:  2011-10       Impact factor: 0.639

Review 2.  [Urolithiasis in children--rational diagnosis, therapy, and metaphylaxis].

Authors:  D Fahlenkamp; B Noack; S Lebentrau; H Belz
Journal:  Urologe A       Date:  2008-05       Impact factor: 0.639

Review 3.  Economic Considerations in the Management of Nephrolithiasis.

Authors:  Daniel Roberson; Colin Sperling; Ankur Shah; Justin Ziemba
Journal:  Curr Urol Rep       Date:  2020-03-31       Impact factor: 3.092

Review 4.  Recent advances in understanding and managing urolithiasis.

Authors:  Walter L Strohmaier
Journal:  F1000Res       Date:  2016-11-08

5.  An empirical study on hospital-based prevention of recurrent urinary stone disease in Germany.

Authors:  Alina Reicherz; Patricia Rausch; Roman Herout; Joachim Noldus; Peter Bach
Journal:  World J Urol       Date:  2021-08-18       Impact factor: 4.226

Review 6.  Economics of stone disease/treatment.

Authors:  Walter Ludwig Strohmaier
Journal:  Arab J Urol       Date:  2012-03-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.